Serum Galectin and Renal Dysfunction in ST-Segment Elevation Myocardial Infarction

Victoria Karetnikova1, Anastasia Osokina1, Olga Gruzdeva2

  • 1Federal State Budgetary Institution "Research Institute for Complex Issues of Cardiovascular Diseases", 6 Sosnovy Boulevard, Kemerovo 650002, Russia; Federal State Budget Educational Institution of Higher Professional Education "Kemerovo State Medical Academy of the Ministry of Health of the Russian Federation", 22a Voroshilov Street, Kemerovo 650029, Russia.

Disease Markers
|March 17, 2016
PubMed

Insights

Serum galectin levels and renal dysfunction predict poor prognosis in ST-elevated myocardial infarction (STEMI) patients one year post-event. Elevated galectin correlates with early post-infarction angina, indicating higher risk.

Area of Science:

  • Cardiology
  • Nephrology
  • Biomarkers

Background:

  • ST-elevated myocardial infarction (STEMI) poses significant risks for both cardiac and renal health.
  • Renal dysfunction is an established predictor of adverse outcomes following STEMI.
  • The role of specific biomarkers like galectin in predicting prognosis in STEMI patients with renal dysfunction requires further elucidation.

Purpose of the Study:

  • To investigate the association between serum galectin levels and renal dysfunction.
  • To evaluate the predictive value of galectin and renal function for in-hospital and one-year prognosis after STEMI.
  • To explore the correlation between elevated galectin levels and early postinfarction angina.

Main Methods:

  • Patients with STEMI were stratified into two groups based on cystatin C-estimated glomerular filtration rate (GFR) on day 12: normal GFR (≥60 mL/min/1.73 m²) and renal dysfunction (RD) (<60 mL/min/1.73 m²).
  • GFR was also estimated using the CKD-EPI equation.
  • Serum galectin levels were measured, and a cut-off value of 17.8 ng/mL was used.

Main Results:

  • A decrease in CKD-EPI estimated GFR was more frequent in patients with RD (41.9%) compared to those with normal renal function (21.3%).
  • Elevated galectin levels (>17.8 ng/mL) were observed in 50.6% of patients with RD versus 32% in the normal GFR group.
  • Both RD and elevated galectin levels independently predicted an adverse one-year prognosis in STEMI patients.
  • Elevated galectin levels showed a direct correlation with early postinfarction angina.

Conclusions:

  • Renal dysfunction and elevated serum galectin levels are independent predictors of adverse prognosis one year after STEMI.
  • Galectin may serve as a valuable biomarker for risk stratification in STEMI patients, particularly those with compromised renal function.
  • The findings highlight the intricate relationship between cardiac events, renal health, and systemic inflammation indicated by galectin.

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.1K
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
314
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
897
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
296
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
548
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
599